Reap Financial Group, LLC Zoetis Inc. Transaction History

Reap Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	BUY	$144.41 - $170.3 $18,917 - $22,309	131 Added 201.54%	196 $30.6 Million
Q1 2025 May 14, 2025	BUY	$156.48 - $175.67 $3,286 - $3,689	21 Added 47.73%	65 $10.7 Million
Q4 2024 Feb 27, 2025	BUY	$162.24 - $194.42 $811 - $972	5 Added 12.82%	44 $7.1 Million
Q3 2024 Feb 27, 2025	BUY	$172.58 - $196.48 $6,730 - $7,662	39 New	39 $7.62 Million

2,057

425M

1.82M

1.94M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $55.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Reap Financial Group, LLC with notifications on news.